Diabetologia

A diabetes drug improves small blood flow in insulin-producing areas through nitric oxide in diabetic mice

Updated

Abstract

Acute pharmacological activation of the glucagon-like peptide-1 receptor (GLP-1R) may enhance islet microvascular flow.

  • Impaired blood flow regulation in the islets is associated with beta cell dysfunction in diabetes.
  • Dysregulation of blood flow is linked to reduced nitric oxide availability due to endothelial dysfunction.
  • The dynamic regulation of islet microvascular flow has not been previously assessed in living organisms.
  • Activation of GLP-1R could potentially improve blood flow in the islets through mechanisms involving nitric oxide.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free